Intrinsiqs

Is BioMarin Pharmaceutical Inc. overvalued?

BioMarin Pharmaceutical Inc. (BMRN) looks fairly valued — trading about 6% below its fair value.

Fairly valued
Current price $57.23 Fair value $60.86
Price
$57.23
Fair value
$60.86
Current P/E
27.5
Normal P/E
29.3
Market cap
$11.09B
Dividend yield
0.0%
Return on equity
-0.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BMRN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.